• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by INVO Fertility Inc.

    12/30/25 2:01:56 PM ET
    $IVF
    Medical/Dental Instruments
    Health Care
    Get the next $IVF alert in real time by email
    DEFA14A 1 formdefa14a.htm DEFA14A

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    SCHEDULE 14A

     

    Proxy Statement Pursuant to Section 14(a) of the

    Securities Exchange Act of 1934

    (Amendment No. )

     

     

     

    Filed by the Registrant  ☒ Filed by a Party other than the Registrant  ☐

     

    Check the appropriate box:

     

    ☐ Preliminary Proxy Statement
       
    ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
       
    ☐ Definitive Proxy Statement
       
    ☒ Definitive Additional Materials
       
    ☐ Soliciting Material Pursuant to §240.14a-12

     

    INVO FERTILITY, INC.

    (Name of Registrant as Specified in Its Charter)

     

    (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

     

    Payment of Filing Fee (Check the appropriate box):

     

    ☒ No fee required.
       
    ☐ Fee paid previously with preliminary materials.
       
    ☐ Fee computed on table in exhibit required by Item 2(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     

     

     
     

     

     

     
     

     

     

     

     

    Get the next $IVF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IVF

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $IVF
    SEC Filings

    View All

    INVO Fertility Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

    8-K - INVO Fertility, Inc. (0001417926) (Filer)

    1/6/26 4:05:44 PM ET
    $IVF
    Medical/Dental Instruments
    Health Care

    SEC Form 424B4 filed by INVO Fertility Inc.

    424B4 - INVO Fertility, Inc. (0001417926) (Filer)

    12/31/25 4:05:18 PM ET
    $IVF
    Medical/Dental Instruments
    Health Care

    SEC Form DEFA14A filed by INVO Fertility Inc.

    DEFA14A - INVO Fertility, Inc. (0001417926) (Filer)

    12/30/25 2:01:56 PM ET
    $IVF
    Medical/Dental Instruments
    Health Care

    $IVF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026

    SARASOTA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (NASDAQ:IVF) ("INVO" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced that it will participate in a webcast fireside chat at the Lytham Partners 2026 Investor Healthcare Summit, taking place virtually on Thursday, January 15, 2026. The webcast will take place at 3:00 p.m. ET on Thursday, January 15, 2026. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/hc2026/ or directly at https://lythampartners.com/hc2026/ivf. A replay will also be avai

    1/13/26 4:15:00 PM ET
    $IVF
    Medical/Dental Instruments
    Health Care

    INVO Fertility Aligns Executive Leadership Structure to Support Growth Strategy

    SARASOTA, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (NASDAQ:IVF) ("INVO" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced changes to its executive leadership team to align its human resources with the Company's growth strategy focused on the acquisition and establishment of fertility clinics and ancillary organizations. Terah Krigsvold, who has served as INVO's controller since December 2020, has been appointed as the Company's new chief financial officer, replacing Andrea Goren. Mr. Goren, who has served as INVO chief financial officer

    12/30/25 4:05:00 PM ET
    $IVF
    Medical/Dental Instruments
    Health Care

    INVO Fertility Signs Definitive Purchase Agreement to Acquire Indiana-Based Fertility Clinic "Family Beginnings"

    SARASOTA, Fla. and INDIANAPOLIS, Dec. 17, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (NASDAQ:IVF) ("INVO" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced that it has signed a definitive purchase agreement to acquire Family Beginnings, P.C., a respected fertility clinic serving patients across Indiana and the broader Midwest. The execution of the purchase agreement marks a critical milestone following the Company's November 27, 2025 announcement of its intent to acquire Family Beginnings, and represents the next key step toward completing the transacti

    12/17/25 9:00:00 AM ET
    $IVF
    Medical/Dental Instruments
    Health Care

    $IVF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Krigsvold Terah Renee claimed ownership of 1 shares (SEC Form 3)

    3 - INVO Fertility, Inc. (0001417926) (Issuer)

    1/13/26 8:03:23 PM ET
    $IVF
    Medical/Dental Instruments
    Health Care

    Director Szot Matthew K sold $6 worth of shares (4 units at $1.52) and disposed of 3 shares, closing all direct ownership in the company (SEC Form 4)

    4 - INVO Fertility, Inc. (0001417926) (Issuer)

    12/5/25 9:40:32 PM ET
    $IVF
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Chief Executive Officer Shum Steve

    4 - INVO Fertility, Inc. (0001417926) (Issuer)

    10/3/25 4:05:15 PM ET
    $IVF
    Medical/Dental Instruments
    Health Care

    $IVF
    Leadership Updates

    Live Leadership Updates

    View All

    INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic "Family Beginnings"

    SARASOTA, Fla. and INDIANAPOLIS, Nov. 28, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (NASDAQ:IVF) ("INVO" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced its intent to acquire Family Beginnings, P.C., a respected fertility clinic serving patients across Indiana and the broader Midwest. The planned acquisition marks INVO's second acquisition after its purchase of Wisconsin Fertility Institute in 2023 and reflects the Company's multi-pronged strategic initiative to build a nationwide network of fertility centers capable of reaching underserved markets an

    11/28/25 1:05:00 PM ET
    $IVF
    Medical/Dental Instruments
    Health Care

    $IVF
    Financials

    Live finance-specific insights

    View All

    INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA

    SARASOTA, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (NASDAQ:IVF) ("INVO Fertility" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics, today announced fourth quarter and full year 2024 financial results. Q4 2024 Financial Highlights (all metrics compared to Q4 2023 unless otherwise noted) Revenue was $1,685,966, an increase of 22% compared to $1,381,754.Consolidated clinic revenue from the Company's INVO Center in Atlanta, Georgia, and fertility clinic in Madison, Wisconsin increased 24% to $1,687,300, compared to $1,362,938.Revenue from

    4/30/25 9:00:49 AM ET
    $IVF
    Medical/Dental Instruments
    Health Care